Cargando…
DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis
Cisplatin (CDDP) based chemotherapy is widely used as the first-line strategy in treating non-small cell lung cancer (NSCLC), especially lung squamous cell carcinoma (LUSC). However, secondary cisplatin resistance majorly undermines the cisplatin efficacy leading to a worse prognosis. In this respec...
Autores principales: | Zhao, Xu, Wang, Jizhao, Zhu, Rui, Zhang, Jing, Zhang, Yunfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546124/ https://www.ncbi.nlm.nih.gov/pubmed/34697393 http://dx.doi.org/10.1038/s41598-021-99555-8 |
Ejemplares similares
-
miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
por: Henriques, Daniel G., et al.
Publicado: (2023) -
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
por: Simiene, Julija, et al.
Publicado: (2023) -
The role of miR-382-5p in glioma cell proliferation, migration and invasion
por: Wang, Jinjin, et al.
Publicado: (2019) -
Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles
por: Zottel, Alja, et al.
Publicado: (2020) -
miR-23a-3p and miR-181a-5p modulate SNAP-25 expression
por: Agostini, Simone, et al.
Publicado: (2023)